Related Experiment Videos
Absence of a specific chromosomal marker in essential thrombocythemia
Cancer Genetics and Cytogenetics
|June 1, 1984
Abstract:
In 33 patients with essential thrombocythemia, a specific chromosomal abnormality ( 21q -) could not be confirmed. All patients in this series met rigid criteria for diagnosis of this myeloproliferative disorder.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
The cancer journal from Scientific American·1995
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Journal of the National Cancer Institute·1993
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.
Leukemia & lymphoma·1993
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Cancer genetics and cytogenetics·2010
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
Cancer genetics and cytogenetics·2010
Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports.
Cancer genetics and cytogenetics·2010
Screening for common copy-number variants in cancer genes.
Cancer genetics and cytogenetics·2010
Trisomy 17 in congenital plexiform (multinodular) cellular schwannoma.
Cancer genetics and cytogenetics·2010
Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization.
Cancer genetics and cytogenetics·2010
Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.
Journal of the American College of Cardiology·2026
A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).
Research and practice in thrombosis and haemostasis·2026
Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.
Research and practice in thrombosis and haemostasis·2026
Retraction: Targeted plasmalogen supplementation: effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons.
Frontiers in cell and developmental biology·2026